Butibufen
CAS: 55837-18-8
Rif. 3D-FB19394
5mg | 174,00 € | ||
10mg | 221,00 € | ||
25mg | 427,00 € | ||
50mg | 606,00 € | ||
100mg | 1.011,00 € |
Informazioni sul prodotto
- a-Ethyl-4-(2-methylpropyl)benzeneacetic acid2-(4-Isobutylphenyl)butyric acidDF 1903Y
- 2-(4-Isobutylphenyl)buttersaeure
- 2-(4-Isobutylphenyl)butyric acid
- 2-(p-Isobutylphenyl)butyrate
- 2-(p-Isobutylphenyl)butyric acid
- 2-[4-(2-Methylpropyl)Phenyl]Butanoic Acid
- Benzeneacetic acid, α-ethyl-4-(2-methylpropyl)-
- Brn 2261197
- Butibufen [INN]
- Butibufene
- Vedi altri sinonimi
- Butibufene [INN-French]
- Butibufeno
- Butibufeno [INN-Spanish]
- Butibufenum
- Butibufenum [INN-Latin]
- Butilopan
- Butyric acid, 2-(4-isobutylphenyl)-
- Df 1903Y
- Ff 106
- Unii-Jss1Tem917
- alpha-Ethyl-4-(2-methylpropyl)benzeneacetic acid
- α-Ethyl-4-(2-methylpropyl)benzeneacetic acid
Butibufen is a new anti-inflammatory drug that has been shown to inhibit the proliferation of tumor cells in vitro and in vivo. It inhibits the growth of cancer cells by inhibiting the actin cytoskeleton, which is necessary for cell migration and invasion. Butibufen also decreases ATP production and induces autophagy, which plays an important role in maintaining cellular homeostasis. The anticancer activity of butibufen may be due to its ability to inhibit the production of reactive oxygen species and reduce oxidative stress.
3-desacetylcefotaxime potassium: 3DCTKP is an antibacterial agent that belongs to the group of β-lactam antibiotics. It is a prodrug that is hydrolyzed in vivo to cefotaxime, its active form. 3-Desacetylcefotaxime potassium has antagonistic effects against clostridium and can be used for the treatment of infections caused by this
Proprietà chimiche
Richiesta tecnica su: 3D-FB19394 Butibufen
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.